Wednesday, October 30, 2024

2:50 PM - 3:35 PM

---

Details

Antimicrobial resistance (AMR) threatens the foundation of modern medicine – antibiotics. Projected to cause more deaths than cancer and cost the global economy USD 100 trillion by 2050, AMR presents both a severe health and economic crisis. As existing antibiotics lose effectiveness, the need for new treatments becomes critical. However, despite the magnitude of this issue, the pipeline for new antibiotics is alarmingly sparse. The World Health Organization (WHO) warns that “innovation is badly lacking”. Solutions are urgently needed. Join us for an engaging discussion on the pressing AMR crisis and how commercial incentives to develop new antibiotics can be realigned to meet this critical demand.

---

Speaker